These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25189786)

  • 21. Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study.
    Tan WC; Bourbeau J; Hernandez P; Chapman KR; Cowie R; FitzGerald JM; Marciniuk DD; Maltais F; Buist AS; O'Donnell DE; Sin DD; Aaron SD;
    Thorax; 2014 Aug; 69(8):709-17. PubMed ID: 24706040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with a low level of physical activity in patients with chronic obstructive pulmonary disease.
    Miravitlles M; Cantoni J; Naberan K
    Lung; 2014 Apr; 192(2):259-65. PubMed ID: 24477375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies.
    Wacker ME; Jörres RA; Karch A; Koch A; Heinrich J; Karrasch S; Schulz H; Peters A; Gläser S; Ewert R; Baumeister SE; Vogelmeier C; Leidl R; Holle R;
    Respir Res; 2016 Jul; 17(1):81. PubMed ID: 27405652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency and characteristics of different clinical phenotypes of chronic obstructive pulmonary disease.
    Miravitlles M; Barrecheguren M; Román-Rodríguez M
    Int J Tuberc Lung Dis; 2015 Aug; 19(8):992-8. PubMed ID: 26162367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status.
    Miravitlles M; Soriano JB; Ancochea J; Muñoz L; Duran-Tauleria E; Sánchez G; Sobradillo V; García-Río F
    Respir Med; 2013 Jul; 107(7):1053-60. PubMed ID: 23597591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilities for asthma and COPD according to category of severity: a comprehensive literature review.
    Einarson TR; Bereza BG; Nielsen TA; Hemels ME
    J Med Econ; 2015; 18(7):550-63. PubMed ID: 25735652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group.
    Högman M; Sulku J; Ställberg B; Janson C; Bröms K; Hedenström H; Lisspers K; Malinovschi A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():165-173. PubMed ID: 29379281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase.
    Miravitlles M; Soler-Cataluña JJ; Calle M; Molina J; Almagro P; Quintano JA; Trigueros JA; Cosío BG; Casanova C; Antonio Riesco J; Simonet P; Rigau D; Soriano JB; Ancochea J
    Arch Bronconeumol; 2017 Jun; 53(6):324-335. PubMed ID: 28477954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD).
    Montes de Oca M; López Varela MV; Laucho-Contreras ME; Casas A; Schiavi E; Rey A; Silva A;
    Arch Bronconeumol; 2017 Mar; 53(3):98-106. PubMed ID: 27956034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution and characteristics of COPD phenotypes - results from the Polish sub-cohort of the POPE study.
    Kania A; Krenke R; Kuziemski K; Czajkowska-Malinowska M; Celejewska-Wójcik N; Kuźnar-Kamińska B; Farnik M; Bokiej J; Miszczuk M; Damps-Konstańska I; Grabicki M; Trzaska-Sobczak M; Sładek K; Batura-Gabryel H; Barczyk A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1613-1621. PubMed ID: 29844667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical activity and quality of life in subjects with chronic disease: chronic obstructive pulmonary disease compared with rheumatoid arthritis and diabetes mellitus.
    Arne M; Janson C; Janson S; Boman G; Lindqvist U; Berne C; Emtner M
    Scand J Prim Health Care; 2009; 27(3):141-7. PubMed ID: 19306158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Yu CH; Yang SC; Chang HY; Hsiue TR
    J Am Geriatr Soc; 2015 Feb; 63(2):244-50. PubMed ID: 25641518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD?
    Barrecheguren M; Román-Rodríguez M; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1745-52. PubMed ID: 26366067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limitation of Activities of Daily Living and Quality of Life Based on COPD Combined Classification.
    Barusso MS; Gianjoppe-Santos J; Basso-Vanelli RP; Regueiro EM; Panin JC; Di Lorenzo VA
    Respir Care; 2015 Mar; 60(3):388-98. PubMed ID: 25492955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa.
    Kokturk N; Abuharbid W; Albanna AS; Gunen H; Gurgun A; Khadadah M; Malvolti E; Soliman M; van Zyl-Smit R; Zidouni N; Alzaabi A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2959-2970. PubMed ID: 31908444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.
    Romem A; Rokach A; Bohadana A; Babai P; Arish N; Azulai H; Glazer M; Izbicki G
    Respiration; 2020; 99(1):35-42. PubMed ID: 31694032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (Gesepoc): The Epoconsul Study.
    Calle Rubio M; Rodríguez Hermosa JL; Soler-Cataluña JJ; López-Campos JL; Alcazar Navarrete B; Soriano JB; Rodríguez Gónzalez-Moro JM; Fuentes Ferrer ME; Miravitlles M;
    Arch Bronconeumol (Engl Ed); 2018 May; 54(5):270-279. PubMed ID: 29361320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Relation Between Clinical Phenotypes, GOLD Groups/Stages and Mortality in COPD Patients - A Prospective Multicenter Study.
    Brat K; Svoboda M; Zatloukal J; Plutinsky M; Volakova E; Popelkova P; Novotna B; Dvorak T; Koblizek V
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1171-1182. PubMed ID: 33953554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea.
    Lim J; Choi SE; Bae E; Kang D; Lim EA; Shin GS
    Health Qual Life Outcomes; 2019 Jun; 17(1):97. PubMed ID: 31170982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.